PerspectivePharmaceutical Toxicity

Improving Risk Assessment

See allHide authors and affiliations

Science Translational Medicine  07 Nov 2012:
Vol. 4, Issue 159, pp. 159ps22
DOI: 10.1126/scitranslmed.3003497

You are currently viewing the abstract.

View Full Text

Abstract

Widespread sharing and analysis of clinical trial data and a U.S. government initiative to engineer nonclinical cell-based models that mimic human biological processes have the potential to improve predictions of drug-related adverse events.

View Full Text